After Palantir’s Blowout Earnings, Here’s Where The Stock Could Head Next

Palantir (NASDAQ: PLTR) conscionable delivered 1 of the astir staggering bundle quarters I person ever covered, and the market's absorption has been oddly muted. Palantir posted $1.94 cardinal successful Q2 2026 revenue, up 92.83% twelvemonth implicit year, yet the banal trades down 29.31% twelvemonth to date. That spread betwixt fundamentals and terms is precisely what our exemplary is trying to terms in.

Our 24/7 Wall St. terms people for Palantir is $157.22, implying 24.83% upside from the existent $125.65 quote, with the proposal acceptable to buy.

24/7 Wall St. Price Target Summary

A Blowout Quarter the Market Has Not Digested

Palantir sits 12% beneath its 52-week precocious of $207.52 and conscionable supra its 52-week debased of $106.37. Shares are down 4.47% implicit the past week and disconnected 18.55% implicit 1 year, adjacent aft climbing 2.1% connected August 3.

Q2 EPS of $0.41 bushed the $0.346 estimation by 46.43%, extending the streak to 9 consecutive beats. U.S. commercialized gross jumped 149% to $764 million, and the Rule of 40 people reached 155%, an astir unheard-of fig astatine this scale.

Why Bulls See a Breakout to $201

Our bull lawsuit pegs Palantir astatine $201.63 wrong 12 months, a 60.08% return. The operator is simple: absorption raised FY2026 gross guidance to $8.150 to $8.158 billion, oregon 82% growth, with adjusted escaped currency travel betwixt $4.5 and $4.7 billion. CEO Alex Karp told investors "demand for AI sovereignty has present been unleashed", and the numbers backmost him.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Palantir didn't marque the cut. Grab the names FREE today.

U.S. commercialized remaining woody worth deed $6.238 billion, up 124%, meaning maturation is booked, not hoped for. If AIP adoption compounds, the expert statement people of $182.20 becomes a level alternatively than a ceiling.

What Could Go Wrong

Our carnivore lawsuit lands astatine $138.77. Palantir trades astatine a trailing P/E of 138 and a guardant P/E of 84, leaving zero borderline for a stumble. Stock-based compensation ran $265 cardinal successful Q2, and insider enactment shows nett selling crossed 70 caller transactions.